Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 54.030
- -2.530-4.47%
Close Feb 25 16:00 ET
- 54.050
- +0.020+0.04%
Post 19:08 ET
4.05BMarket Cap-15.53P/E (TTM)
56.140High53.310Low3.38MVolume55.950Open56.560Pre Close183.25MTurnover4.59%Turnover RatioLossP/E (Static)74.94MShares62.00052wk High8.42P/B3.98BFloat Cap28.21052wk Low--Dividend TTM73.69MShs Float96.480Historical High--Div YieldTTM5.00%Amplitude13.600Historical Low54.194Avg Price1Lot Size
SpringWorks Therapeutics News
J.P. Morgan Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $70
J.P. Morgan Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)
SpringWorks Therapeutics Insider Sold Shares Worth $2,866,534, According to a Recent SEC Filing
Assessing SpringWorks Therapeutics: Insights From 6 Financial Analysts
Why SpringWorks Therapeutics, Inc. (SWTX) Is the Best Performing Pharma Stock So Far in 2025
Guggenheim Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Cuts Target Price to $77
SpringWorks Therapeutics Analyst Ratings
H.C. Wainwright Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $74
SpringWorks' Q4 Loss Wider Than Expected, Revenues Beat Estimates
A Quick Look at Today's Ratings for SpringWorks Therapeutics(SWTX.US), With a Forecast Between $63 to $87
Express News | SpringWorks Therapeutics Inc : Guggenheim Cuts Target Price to $77 From $78
Here's Why We're Not At All Concerned With SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation
Subdued Growth No Barrier To SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) With Shares Advancing 65%
SpringWorks Therapeutics Reports Strong 2024 Performance
Analysts Are Bullish on These Healthcare Stocks: Aura Biosciences Inc (AURA), Springworks Therapeutics (SWTX)
Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday
SpringWorks Therapeutics Jumps After Results, Conference Call Cancellation
Springworks Therapeutics Q4 Net Loss Narrows
SpringWorks Therapeutics | 10-K: FY2024 Annual Report
SpringWorks Therapeutics | 8-K: SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.